Investigation of an outbreak of acute respiratory disease in an indigenous village in Brazil: Contribution of Influenza A(H1N1)pdm09 and human respiratory syncytial viruses.
Identifieur interne : 000119 ( PubMed/Corpus ); précédent : 000118; suivant : 000120Investigation of an outbreak of acute respiratory disease in an indigenous village in Brazil: Contribution of Influenza A(H1N1)pdm09 and human respiratory syncytial viruses.
Auteurs : Andrey Moreira Cardoso ; Paola Cristina Resende ; Enny S. Paixao ; Felipe G. Tavares ; Yasmin N. Farias ; Carla Tatiana G. Barreto ; Lídia N. Pantoja ; Fernanda L. Ferreira ; André Luiz Martins ; Ângela Barbosa Lima ; Daniella A. Fernandes ; Patrícia Machado Sanches ; Walquiria A F. Almeida ; Laura C. Rodrigues ; Marilda M. SiqueiraSource :
- PloS one [ 1932-6203 ] ; 2019.
English descriptors
- KwdEn :
- Adolescent, Brazil (epidemiology), Child, Child, Preschool, Disease Outbreaks, Female, Humans, Infant, Influenza A Virus, H1N1 Subtype (pathogenicity), Influenza Vaccines (therapeutic use), Influenza, Human (epidemiology), Influenza, Human (prevention & control), Influenza, Human (virology), Male, Respiration Disorders (epidemiology), Respiration Disorders (prevention & control), Respiration Disorders (virology), Respiratory Tract Infections (epidemiology), Respiratory Tract Infections (prevention & control), Respiratory Tract Infections (virology), Seasons, Vaccination.
- MESH :
- chemical , therapeutic use : Influenza Vaccines.
- geographic , epidemiology : Brazil.
- epidemiology : Influenza, Human, Respiration Disorders, Respiratory Tract Infections.
- pathogenicity : Influenza A Virus, H1N1 Subtype.
- prevention & control : Influenza, Human, Respiration Disorders, Respiratory Tract Infections.
- virology : Influenza, Human, Respiration Disorders, Respiratory Tract Infections.
- Adolescent, Child, Child, Preschool, Disease Outbreaks, Female, Humans, Infant, Male, Seasons, Vaccination.
Abstract
Analyses of the 2009 H1N1 influenza pandemic and post-pandemic years showed high attack rates and severity among indigenous populations. This study presents the characteristics of the first documented influenza outbreak in indigenous peoples in Brazil, that occurred from 30th March to 14th April 2016 in a Guarani village in Southeast Region. Acute respiratory infections were prospectively investigated. The majority of the 73 cases were influenza-like illness (ILI) (63.0%) or severe acute respiratory infection (SARI) (20.5%). The ILI+SARI attack rate (35.9%) decreased with increasing age. There was a high influenza vaccination rate (86.3%), but no statistically significant difference in vaccination rates between severe and non-severe cases was seen (p = 0.334). Molecular analyses of 19.2% of the cases showed 100% positivity for influenza A(H1N1)pdm09 and/or hRSV. Influenza A(H1N1)pdm09 was included in the 6B.1 genetic group, a distinct cluster with 13 amino acid substitutions of A/California/07/2009-like. The hRSV were clustered in the BA-like genetic group. The early arrival of the influenza season overlapping usual hRSV season, the circulation of a drifted influenza virus not covered by vaccine and the high prevalence of risk factors for infection and severity in the village jointly can explain the high attack rate of ARI, even with a high rate of influenza vaccination. The results reinforce the importance of surveillance of respiratory viruses, timely vaccination and controlling risk factors for infection and severity of in the indigenous populations in order to preventing disease and related deaths, particularly in children.
DOI: 10.1371/journal.pone.0218925
PubMed: 31283762
Links to Exploration step
pubmed:31283762Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Investigation of an outbreak of acute respiratory disease in an indigenous village in Brazil: Contribution of Influenza A(H1N1)pdm09 and human respiratory syncytial viruses.</title><author><name sortKey="Cardoso, Andrey Moreira" sort="Cardoso, Andrey Moreira" uniqKey="Cardoso A" first="Andrey Moreira" last="Cardoso">Andrey Moreira Cardoso</name><affiliation><nlm:affiliation>Fundação Oswaldo Cruz, Rio de Janeiro, RJ, Brazil.</nlm:affiliation></affiliation></author><author><name sortKey="Resende, Paola Cristina" sort="Resende, Paola Cristina" uniqKey="Resende P" first="Paola Cristina" last="Resende">Paola Cristina Resende</name><affiliation><nlm:affiliation>Instituto Oswaldo Cruz-Fiocruz, Rio de Janeiro, RJ, Brazil.</nlm:affiliation></affiliation></author><author><name sortKey="Paixao, Enny S" sort="Paixao, Enny S" uniqKey="Paixao E" first="Enny S" last="Paixao">Enny S. Paixao</name><affiliation><nlm:affiliation>London School of Hygiene and Tropical Medicine, London, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Tavares, Felipe G" sort="Tavares, Felipe G" uniqKey="Tavares F" first="Felipe G" last="Tavares">Felipe G. Tavares</name><affiliation><nlm:affiliation>Universidade Federal Fluminense, Niterói, RJ, Brazil.</nlm:affiliation></affiliation></author><author><name sortKey="Farias, Yasmin N" sort="Farias, Yasmin N" uniqKey="Farias Y" first="Yasmin N" last="Farias">Yasmin N. Farias</name><affiliation><nlm:affiliation>Fundação Oswaldo Cruz, Rio de Janeiro, RJ, Brazil.</nlm:affiliation></affiliation></author><author><name sortKey="Barreto, Carla Tatiana G" sort="Barreto, Carla Tatiana G" uniqKey="Barreto C" first="Carla Tatiana G" last="Barreto">Carla Tatiana G. Barreto</name><affiliation><nlm:affiliation>Universidade do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.</nlm:affiliation></affiliation></author><author><name sortKey="Pantoja, Lidia N" sort="Pantoja, Lidia N" uniqKey="Pantoja L" first="Lídia N" last="Pantoja">Lídia N. Pantoja</name><affiliation><nlm:affiliation>Fundação Oswaldo Cruz, Rio de Janeiro, RJ, Brazil.</nlm:affiliation></affiliation></author><author><name sortKey="Ferreira, Fernanda L" sort="Ferreira, Fernanda L" uniqKey="Ferreira F" first="Fernanda L" last="Ferreira">Fernanda L. Ferreira</name><affiliation><nlm:affiliation>Secretaria Especial de Saúde Indígena, Curitiba, PR, Brazil.</nlm:affiliation></affiliation></author><author><name sortKey="Martins, Andre Luiz" sort="Martins, Andre Luiz" uniqKey="Martins A" first="André Luiz" last="Martins">André Luiz Martins</name><affiliation><nlm:affiliation>Secretaria Especial de Saúde Indígena, Curitiba, PR, Brazil.</nlm:affiliation></affiliation></author><author><name sortKey="Lima, Angela Barbosa" sort="Lima, Angela Barbosa" uniqKey="Lima A" first="Ângela Barbosa" last="Lima">Ângela Barbosa Lima</name><affiliation><nlm:affiliation>Secretaria Especial de Saúde Indígena, Curitiba, PR, Brazil.</nlm:affiliation></affiliation></author><author><name sortKey="Fernandes, Daniella A" sort="Fernandes, Daniella A" uniqKey="Fernandes D" first="Daniella A" last="Fernandes">Daniella A. Fernandes</name><affiliation><nlm:affiliation>Secretaria Especial de Saúde Indígena, Curitiba, PR, Brazil.</nlm:affiliation></affiliation></author><author><name sortKey="Sanches, Patricia Machado" sort="Sanches, Patricia Machado" uniqKey="Sanches P" first="Patrícia Machado" last="Sanches">Patrícia Machado Sanches</name><affiliation><nlm:affiliation>Secretaria Municipal de Saúde de Paraty, Paraty, RJ, Brazil.</nlm:affiliation></affiliation></author><author><name sortKey="Almeida, Walquiria A F" sort="Almeida, Walquiria A F" uniqKey="Almeida W" first="Walquiria A F" last="Almeida">Walquiria A F. Almeida</name><affiliation><nlm:affiliation>Secretaria de Vigilância em Saúde, Brasília, DF, Brazil.</nlm:affiliation></affiliation></author><author><name sortKey="Rodrigues, Laura C" sort="Rodrigues, Laura C" uniqKey="Rodrigues L" first="Laura C" last="Rodrigues">Laura C. Rodrigues</name><affiliation><nlm:affiliation>London School of Hygiene and Tropical Medicine, London, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Siqueira, Marilda M" sort="Siqueira, Marilda M" uniqKey="Siqueira M" first="Marilda M" last="Siqueira">Marilda M. Siqueira</name><affiliation><nlm:affiliation>Instituto Oswaldo Cruz-Fiocruz, Rio de Janeiro, RJ, Brazil.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2019">2019</date><idno type="RBID">pubmed:31283762</idno><idno type="pmid">31283762</idno><idno type="doi">10.1371/journal.pone.0218925</idno><idno type="wicri:Area/PubMed/Corpus">000119</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000119</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Investigation of an outbreak of acute respiratory disease in an indigenous village in Brazil: Contribution of Influenza A(H1N1)pdm09 and human respiratory syncytial viruses.</title><author><name sortKey="Cardoso, Andrey Moreira" sort="Cardoso, Andrey Moreira" uniqKey="Cardoso A" first="Andrey Moreira" last="Cardoso">Andrey Moreira Cardoso</name><affiliation><nlm:affiliation>Fundação Oswaldo Cruz, Rio de Janeiro, RJ, Brazil.</nlm:affiliation></affiliation></author><author><name sortKey="Resende, Paola Cristina" sort="Resende, Paola Cristina" uniqKey="Resende P" first="Paola Cristina" last="Resende">Paola Cristina Resende</name><affiliation><nlm:affiliation>Instituto Oswaldo Cruz-Fiocruz, Rio de Janeiro, RJ, Brazil.</nlm:affiliation></affiliation></author><author><name sortKey="Paixao, Enny S" sort="Paixao, Enny S" uniqKey="Paixao E" first="Enny S" last="Paixao">Enny S. Paixao</name><affiliation><nlm:affiliation>London School of Hygiene and Tropical Medicine, London, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Tavares, Felipe G" sort="Tavares, Felipe G" uniqKey="Tavares F" first="Felipe G" last="Tavares">Felipe G. Tavares</name><affiliation><nlm:affiliation>Universidade Federal Fluminense, Niterói, RJ, Brazil.</nlm:affiliation></affiliation></author><author><name sortKey="Farias, Yasmin N" sort="Farias, Yasmin N" uniqKey="Farias Y" first="Yasmin N" last="Farias">Yasmin N. Farias</name><affiliation><nlm:affiliation>Fundação Oswaldo Cruz, Rio de Janeiro, RJ, Brazil.</nlm:affiliation></affiliation></author><author><name sortKey="Barreto, Carla Tatiana G" sort="Barreto, Carla Tatiana G" uniqKey="Barreto C" first="Carla Tatiana G" last="Barreto">Carla Tatiana G. Barreto</name><affiliation><nlm:affiliation>Universidade do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.</nlm:affiliation></affiliation></author><author><name sortKey="Pantoja, Lidia N" sort="Pantoja, Lidia N" uniqKey="Pantoja L" first="Lídia N" last="Pantoja">Lídia N. Pantoja</name><affiliation><nlm:affiliation>Fundação Oswaldo Cruz, Rio de Janeiro, RJ, Brazil.</nlm:affiliation></affiliation></author><author><name sortKey="Ferreira, Fernanda L" sort="Ferreira, Fernanda L" uniqKey="Ferreira F" first="Fernanda L" last="Ferreira">Fernanda L. Ferreira</name><affiliation><nlm:affiliation>Secretaria Especial de Saúde Indígena, Curitiba, PR, Brazil.</nlm:affiliation></affiliation></author><author><name sortKey="Martins, Andre Luiz" sort="Martins, Andre Luiz" uniqKey="Martins A" first="André Luiz" last="Martins">André Luiz Martins</name><affiliation><nlm:affiliation>Secretaria Especial de Saúde Indígena, Curitiba, PR, Brazil.</nlm:affiliation></affiliation></author><author><name sortKey="Lima, Angela Barbosa" sort="Lima, Angela Barbosa" uniqKey="Lima A" first="Ângela Barbosa" last="Lima">Ângela Barbosa Lima</name><affiliation><nlm:affiliation>Secretaria Especial de Saúde Indígena, Curitiba, PR, Brazil.</nlm:affiliation></affiliation></author><author><name sortKey="Fernandes, Daniella A" sort="Fernandes, Daniella A" uniqKey="Fernandes D" first="Daniella A" last="Fernandes">Daniella A. Fernandes</name><affiliation><nlm:affiliation>Secretaria Especial de Saúde Indígena, Curitiba, PR, Brazil.</nlm:affiliation></affiliation></author><author><name sortKey="Sanches, Patricia Machado" sort="Sanches, Patricia Machado" uniqKey="Sanches P" first="Patrícia Machado" last="Sanches">Patrícia Machado Sanches</name><affiliation><nlm:affiliation>Secretaria Municipal de Saúde de Paraty, Paraty, RJ, Brazil.</nlm:affiliation></affiliation></author><author><name sortKey="Almeida, Walquiria A F" sort="Almeida, Walquiria A F" uniqKey="Almeida W" first="Walquiria A F" last="Almeida">Walquiria A F. Almeida</name><affiliation><nlm:affiliation>Secretaria de Vigilância em Saúde, Brasília, DF, Brazil.</nlm:affiliation></affiliation></author><author><name sortKey="Rodrigues, Laura C" sort="Rodrigues, Laura C" uniqKey="Rodrigues L" first="Laura C" last="Rodrigues">Laura C. Rodrigues</name><affiliation><nlm:affiliation>London School of Hygiene and Tropical Medicine, London, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Siqueira, Marilda M" sort="Siqueira, Marilda M" uniqKey="Siqueira M" first="Marilda M" last="Siqueira">Marilda M. Siqueira</name><affiliation><nlm:affiliation>Instituto Oswaldo Cruz-Fiocruz, Rio de Janeiro, RJ, Brazil.</nlm:affiliation></affiliation></author></analytic><series><title level="j">PloS one</title><idno type="eISSN">1932-6203</idno><imprint><date when="2019" type="published">2019</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Brazil (epidemiology)</term><term>Child</term><term>Child, Preschool</term><term>Disease Outbreaks</term><term>Female</term><term>Humans</term><term>Infant</term><term>Influenza A Virus, H1N1 Subtype (pathogenicity)</term><term>Influenza Vaccines (therapeutic use)</term><term>Influenza, Human (epidemiology)</term><term>Influenza, Human (prevention & control)</term><term>Influenza, Human (virology)</term><term>Male</term><term>Respiration Disorders (epidemiology)</term><term>Respiration Disorders (prevention & control)</term><term>Respiration Disorders (virology)</term><term>Respiratory Tract Infections (epidemiology)</term><term>Respiratory Tract Infections (prevention & control)</term><term>Respiratory Tract Infections (virology)</term><term>Seasons</term><term>Vaccination</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Brazil</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term><term>Respiration Disorders</term><term>Respiratory Tract Infections</term></keywords><keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>Influenza A Virus, H1N1 Subtype</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term><term>Respiration Disorders</term><term>Respiratory Tract Infections</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Influenza, Human</term><term>Respiration Disorders</term><term>Respiratory Tract Infections</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Child</term><term>Child, Preschool</term><term>Disease Outbreaks</term><term>Female</term><term>Humans</term><term>Infant</term><term>Male</term><term>Seasons</term><term>Vaccination</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Analyses of the 2009 H1N1 influenza pandemic and post-pandemic years showed high attack rates and severity among indigenous populations. This study presents the characteristics of the first documented influenza outbreak in indigenous peoples in Brazil, that occurred from 30th March to 14th April 2016 in a Guarani village in Southeast Region. Acute respiratory infections were prospectively investigated. The majority of the 73 cases were influenza-like illness (ILI) (63.0%) or severe acute respiratory infection (SARI) (20.5%). The ILI+SARI attack rate (35.9%) decreased with increasing age. There was a high influenza vaccination rate (86.3%), but no statistically significant difference in vaccination rates between severe and non-severe cases was seen (p = 0.334). Molecular analyses of 19.2% of the cases showed 100% positivity for influenza A(H1N1)pdm09 and/or hRSV. Influenza A(H1N1)pdm09 was included in the 6B.1 genetic group, a distinct cluster with 13 amino acid substitutions of A/California/07/2009-like. The hRSV were clustered in the BA-like genetic group. The early arrival of the influenza season overlapping usual hRSV season, the circulation of a drifted influenza virus not covered by vaccine and the high prevalence of risk factors for infection and severity in the village jointly can explain the high attack rate of ARI, even with a high rate of influenza vaccination. The results reinforce the importance of surveillance of respiratory viruses, timely vaccination and controlling risk factors for infection and severity of in the indigenous populations in order to preventing disease and related deaths, particularly in children.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31283762</PMID><DateCompleted><Year>2020</Year><Month>02</Month><Day>18</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>7</Issue><PubDate><Year>2019</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS ONE</ISOAbbreviation></Journal><ArticleTitle>Investigation of an outbreak of acute respiratory disease in an indigenous village in Brazil: Contribution of Influenza A(H1N1)pdm09 and human respiratory syncytial viruses.</ArticleTitle><Pagination><MedlinePgn>e0218925</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0218925</ELocationID><Abstract><AbstractText>Analyses of the 2009 H1N1 influenza pandemic and post-pandemic years showed high attack rates and severity among indigenous populations. This study presents the characteristics of the first documented influenza outbreak in indigenous peoples in Brazil, that occurred from 30th March to 14th April 2016 in a Guarani village in Southeast Region. Acute respiratory infections were prospectively investigated. The majority of the 73 cases were influenza-like illness (ILI) (63.0%) or severe acute respiratory infection (SARI) (20.5%). The ILI+SARI attack rate (35.9%) decreased with increasing age. There was a high influenza vaccination rate (86.3%), but no statistically significant difference in vaccination rates between severe and non-severe cases was seen (p = 0.334). Molecular analyses of 19.2% of the cases showed 100% positivity for influenza A(H1N1)pdm09 and/or hRSV. Influenza A(H1N1)pdm09 was included in the 6B.1 genetic group, a distinct cluster with 13 amino acid substitutions of A/California/07/2009-like. The hRSV were clustered in the BA-like genetic group. The early arrival of the influenza season overlapping usual hRSV season, the circulation of a drifted influenza virus not covered by vaccine and the high prevalence of risk factors for infection and severity in the village jointly can explain the high attack rate of ARI, even with a high rate of influenza vaccination. The results reinforce the importance of surveillance of respiratory viruses, timely vaccination and controlling risk factors for infection and severity of in the indigenous populations in order to preventing disease and related deaths, particularly in children.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cardoso</LastName><ForeName>Andrey Moreira</ForeName><Initials>AM</Initials><Identifier Source="ORCID">0000-0002-7591-7791</Identifier><AffiliationInfo><Affiliation>Fundação Oswaldo Cruz, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>London School of Hygiene and Tropical Medicine, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Resende</LastName><ForeName>Paola Cristina</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>Instituto Oswaldo Cruz-Fiocruz, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paixao</LastName><ForeName>Enny S</ForeName><Initials>ES</Initials><AffiliationInfo><Affiliation>London School of Hygiene and Tropical Medicine, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tavares</LastName><ForeName>Felipe G</ForeName><Initials>FG</Initials><AffiliationInfo><Affiliation>Universidade Federal Fluminense, Niterói, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farias</LastName><ForeName>Yasmin N</ForeName><Initials>YN</Initials><AffiliationInfo><Affiliation>Fundação Oswaldo Cruz, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barreto</LastName><ForeName>Carla Tatiana G</ForeName><Initials>CTG</Initials><AffiliationInfo><Affiliation>Universidade do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pantoja</LastName><ForeName>Lídia N</ForeName><Initials>LN</Initials><AffiliationInfo><Affiliation>Fundação Oswaldo Cruz, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferreira</LastName><ForeName>Fernanda L</ForeName><Initials>FL</Initials><AffiliationInfo><Affiliation>Secretaria Especial de Saúde Indígena, Curitiba, PR, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martins</LastName><ForeName>André Luiz</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Secretaria Especial de Saúde Indígena, Curitiba, PR, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lima</LastName><ForeName>Ângela Barbosa</ForeName><Initials>ÂB</Initials><AffiliationInfo><Affiliation>Secretaria Especial de Saúde Indígena, Curitiba, PR, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fernandes</LastName><ForeName>Daniella A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Secretaria Especial de Saúde Indígena, Curitiba, PR, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanches</LastName><ForeName>Patrícia Machado</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Secretaria Municipal de Saúde de Paraty, Paraty, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Almeida</LastName><ForeName>Walquiria A F</ForeName><Initials>WAF</Initials><AffiliationInfo><Affiliation>Secretaria de Vigilância em Saúde, Brasília, DF, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodrigues</LastName><ForeName>Laura C</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>London School of Hygiene and Tropical Medicine, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siqueira</LastName><ForeName>Marilda M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Instituto Oswaldo Cruz-Fiocruz, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>07</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Nature. 2020 Apr;580(7802):185</RefSource><PMID Version="1">32265568</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001938" MajorTopicYN="N" Type="Geographic">Brazil</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053118" MajorTopicYN="N">Influenza A Virus, H1N1 Subtype</DescriptorName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012120" MajorTopicYN="N">Respiration Disorders</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="N">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012621" MajorTopicYN="N">Seasons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>09</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>06</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>2</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31283762</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0218925</ArticleId><ArticleId IdType="pii">PONE-D-18-28246</ArticleId><ArticleId IdType="pmc">PMC6613774</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Trop Med Int Health. 2013 May;18(5):596-607</Citation><ArticleIdList><ArticleId IdType="pubmed">23489343</ArticleId></ArticleIdList></Reference><Reference><Citation>Wkly Epidemiol Rec. 2015 Oct 9;90(41):545-59</Citation><ArticleIdList><ArticleId IdType="pubmed">26454888</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2011 Jan 1;52 Suppl 1:S189-97</Citation><ArticleIdList><ArticleId IdType="pubmed">21342894</ArticleId></ArticleIdList></Reference><Reference><Citation>Wkly Epidemiol Rec. ;91(41):469-84</Citation><ArticleIdList><ArticleId IdType="pubmed">27758094</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Morb Mortal Wkly Rep. 2016 Jun 10;65(22):567-75</Citation><ArticleIdList><ArticleId IdType="pubmed">27281364</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Public Health. 2012 Mar-Apr;103(2):90-3</Citation><ArticleIdList><ArticleId IdType="pubmed">22530528</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2010 Jun 17;28(27):4376-83</Citation><ArticleIdList><ArticleId IdType="pubmed">20447477</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Public Health. 2009 Oct;99 Suppl 2:S271-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19461107</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Microbiol. 2007 Sep;45(9):3022-30</Citation><ArticleIdList><ArticleId IdType="pubmed">17609323</ArticleId></ArticleIdList></Reference><Reference><Citation>Aust N Z J Public Health. 2015 Feb;39(1):15-20</Citation><ArticleIdList><ArticleId IdType="pubmed">25560972</ArticleId></ArticleIdList></Reference><Reference><Citation>Rev Inst Med Trop Sao Paulo. 2017 Apr 03;59:e9</Citation><ArticleIdList><ArticleId IdType="pubmed">28380120</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2014 Jan 21;111(3):1049-54</Citation><ArticleIdList><ArticleId IdType="pubmed">24395804</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Infect Dis. 2013 Jan 07;13:6</Citation><ArticleIdList><ArticleId IdType="pubmed">23289407</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Health. 2015 Nov;7(6):412-9</Citation><ArticleIdList><ArticleId IdType="pubmed">25908715</ArticleId></ArticleIdList></Reference><Reference><Citation>Braz J Infect Dis. 2013 Jan-Feb;17(1):62-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23287541</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2009 Oct 22;14(42):</Citation><ArticleIdList><ArticleId IdType="pubmed">19883543</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2017 Nov 16;12(11):e0188267</Citation><ArticleIdList><ArticleId IdType="pubmed">29145498</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Epidemiol. 2011 Dec 1;174(11 Suppl):S89-96</Citation><ArticleIdList><ArticleId IdType="pubmed">22135397</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2012 Jan;86(1):11-8</Citation><ArticleIdList><ArticleId IdType="pubmed">22013031</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2015 Sep 02;10(9):e0136526</Citation><ArticleIdList><ArticleId IdType="pubmed">26332375</ArticleId></ArticleIdList></Reference><Reference><Citation>Influenza Other Respir Viruses. 2013 Nov;7(6):1409-15</Citation><ArticleIdList><ArticleId IdType="pubmed">23879801</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Vaccin Immunother. 2016 Apr 2;12(4):848-56</Citation><ArticleIdList><ArticleId IdType="pubmed">26857450</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2014 May 23;32(25):2958-64</Citation><ArticleIdList><ArticleId IdType="pubmed">24709586</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Infect Dis J. 2012 Mar;31(3):309-12</Citation><ArticleIdList><ArticleId IdType="pubmed">22315004</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Public Health. 2013 Jan 19;13:52</Citation><ArticleIdList><ArticleId IdType="pubmed">23331985</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Equity Health. 2013 Apr 03;12:23</Citation><ArticleIdList><ArticleId IdType="pubmed">23552397</ArticleId></ArticleIdList></Reference><Reference><Citation>Influenza Other Respir Viruses. 2013 Nov;7(6):1361-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23721100</ArticleId></ArticleIdList></Reference><Reference><Citation>Med J Aust. 2010 May 17;192(10):617-22</Citation><ArticleIdList><ArticleId IdType="pubmed">20477746</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2006 Jan;80(2):975-84</Citation><ArticleIdList><ArticleId IdType="pubmed">16378999</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pediatr (Rio J). 2013 Sep-Oct;89(5):421-3</Citation><ArticleIdList><ArticleId IdType="pubmed">23871497</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Virol. 2003 Nov;84(Pt 11):3115-3120</Citation><ArticleIdList><ArticleId IdType="pubmed">14573817</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2011 Sep;17(9):1615-23</Citation><ArticleIdList><ArticleId IdType="pubmed">21888786</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000119 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000119 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= PandemieGrippaleV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:31283762
|texte= Investigation of an outbreak of acute respiratory disease in an indigenous village in Brazil: Contribution of Influenza A(H1N1)pdm09 and human respiratory syncytial viruses.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:31283762" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a PandemieGrippaleV1
| This area was generated with Dilib version V0.6.34. |  |